Which sedative works best for kids after cleft surgery? new study aims to find out
NCT ID NCT07340008
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares three different sedatives (ketamine, nalbuphine, and dexmedetomidine) given to 60 children aged 6 months to 3 years who need stitches removed after cleft lip or palate surgery. The goal is to see which drug works fastest and safest to keep the child calm and comfortable during the procedure. Results will help doctors choose the best option for this common, minor surgery.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 60 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Sep 2025
- Expected to finish
-
Jan 2029
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
6 months to 3 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion criteria: * Age 6 months to 3 years * Scheduled for suture removal after surgery for congenital cleft of the palate, alveolar ridge, or lip * American Society of Anesthesiologists (ASA) physical status I or II * Written informed consent obtained from parents or legal guardians * Slovene-speaking family to ensure understanding and compliance * No contraindications to the use of study medications Exclusion criteria: * Known allergy or hypersensitivity to ketamine, nalbuphine, or dexmedetomidine * ASA physical status greater than II * Significant neurological, psychiatric, or respiratory disorder * Active or recent upper respiratory tract infection * Refusal of parental or guardian consent * Developmental disorder affecting communication or cooperation
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Alveolar ridge defect are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Department of Maxillofacial and Oral Surgery, University Medical Centre Ljubljana
RECRUITINGLjubljana, 1000, Slovenia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Timing of cleft palate repair may shape a child's speech
- Can a nerve block Add-On calm pain and agitation after cleft palate repair?
- Can the pace of speech therapy make a difference for kids with cleft palate?
- Could a phone app help parents of kids with special needs thrive?
- Can a blood-derived patch strengthen cleft palate repair?
- Baby teeth stem cells may spare kids a second surgery for cleft palate repair